| 000 | 01610 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513190309.0 | ||
| 264 | 0 | _c19991026 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a0168-3659 | ||
| 024 | 7 |
_a10.1016/s0168-3659(99)00077-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOkimoto, K | |
| 245 | 0 | 0 |
_aFactors affecting membrane-controlled drug release for an osmotic pump tablet (OPT) utilizing (SBE)(7m)-beta-CD as both a solubilizer and osmotic agent. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cAug 1999 |
||
| 300 |
_a311-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacokinetics |
| 650 | 0 | 4 |
_aChlorpromazine _xpharmacokinetics |
| 650 | 0 | 4 |
_aCyclodextrins _xchemistry |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aMembranes, Artificial |
| 650 | 0 | 4 | _aMicroscopy, Electron, Scanning |
| 650 | 0 | 4 | _aOsmosis |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 | _aTablets |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aOhike, A | |
| 700 | 1 | _aIbuki, R | |
| 700 | 1 | _aAoki, O | |
| 700 | 1 | _aOhnishi, N | |
| 700 | 1 | _aRajewski, R A | |
| 700 | 1 | _aStella, V J | |
| 700 | 1 | _aIrie, T | |
| 700 | 1 | _aUekama, K | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 60 _gno. 2-3 _gp. 311-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-3659(99)00077-2 _zAvailable from publisher's website |
| 999 |
_c10383281 _d10383281 |
||